We assessed the following variables and outcomes: aneurysm rupture status, aneurysm adjunctive treatment technique (balloon-assisted Background and Purpose-Use of endovascular coiling for treatment of ruptured and unruptured intracranial aneurysms (IAs) in the elderly is increasing. We performed a meta-analysis of the literature examining clinical and angiographic outcomes for treatment of IAs in the elderly. Methods-We performed a comprehensive review of the literature from 1995 to 2012, reporting series of patients ≥65 years of age with ruptured or unruptured IAs treated with endovascular approach. Event rates were pooled across studies using random effects meta-analysis. Results-A total of 21 studies reporting on 1511 patients were included. Long-term aneurysm occlusion rates were 79% (95% confidence interval [CI], 70%-85%). Perioperative stroke occurred in 4% (95% CI, 3%-6%), with similar rates between patients with ruptured (5%; 95% CI, 3%-7%) and unruptured aneurysms (4%; 95% CI, 1%-14%; P=0.68).
ndovascular coiling has emerged as a valid alternative to surgical clipping in elderly patients with aneurysmal subarachnoid hemorrhage (SAH) and unruptured intracranial aneurysms (IAs). Several studies have examined the risks associated with endovascular treatment of ruptured [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and unruptured [19] [20] [21] IAs in elderly patients, but large series are relatively lacking. To understand safety and efficacy profiles associated with the endovascular treatment of IAs in patients ≥65 years of age, we performed a meta-analysis of the literature.
Material and Methods

Study Selection
A comprehensive review of the literature was performed using the key words intracranial aneurysm, unruptured aneurysm, berry aneurysm, cerebral aneurysm, SAH, elderly, coiling, embolization, age, endovascular, and older, to search PubMed, Ovid Medline, Ovid EMBASE, Scopus, and Web of Science database. All studies reporting series of elderly patients treated with endovascular coiling for IAs were selected. The inclusion criteria were the following: English language, ≥65 years of age, and availability of clinical outcome data (perioperative and postoperative complications, occlusion rates, and outcome). The exclusion criteria were the following: studies with <10 patients, review articles, guidelines, technical notes, and series in which all patients were selected because of having a certain major complication. Two reviewers (W.B. and C.L.S.) independently selected the included studies. The age cutoff of ≥65 years was chosen based on a study showing that although the relationship between age and outcome after aneurysmal SAH is linear, there seems to be an increased risk for poor outcome (at least in patients with ruptured aneurysms) after the age of 65. 22 Full-text articles were searched for data on demographics, aneurysm location and size, aneurysm rupture status, treatment modalities, occlusion rates, procedure failure, procedural-related morbidity and mortality, procedural-related complications, and clinical outcome. Two reviewers (W.B and C.L.S.) independently abstracted data from the included articles. Any differences were resolved by consulting with a third author (G.L.)
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coiling, stent-assisted coiling, secondary clipping), angiographic outcomes (immediate complete/near complete occlusion, long-term complete/near complete occlusion, procedural failure, and rerupture), perioperative complications occurring within 30 days of the procedure (intraoperative rupture, parent artery occlusion, transient ischemic attack, vasospasm, stroke), perioperative morbidity and mortality, and long-term clinical outcome. Perioperative mortality was defined as all-cause mortality occurring within 30 days of the procedure. Perioperative morbidity was defined as permanent morbidity resulting from a procedural-related complication. Long-term complete/near complete aneurysm occlusion rates were determined at 2 time periods: (1) 6 to 12 months after treatment and (2) >12 months after treatment. Clinical outcome was scored according to the Glasgow Outcome Scale. For studies reporting the clinical outcome according to the modified Rankin Scale or World Federation of Neurological Surgeons Grading System, the equivalent score on Glasgow Outcome Scale was calculated. Because some studies defined good final outcome as good recovery (GR) plus moderate disability (MD), we used GR+MD as a primary clinical outcome, but also tested separately the subgroups of studies specifically reporting GR at clinical follow-up. Other clinical outcomes studied were all-cause severe disability and all-cause mortality. Clinical outcome was determined at 2 time periods: (1) 6 to 12 months after treatment and (2) >12 months after treatment.
Statistical Analysis
We assessed the cumulative incidence (event rate) and 95% confidence interval (CI) for each outcome. Cumulative outcomes (ruptured+unruptured) were also calculated for all outcomes. Perioperative complication rates and clinical outcomes were calculated separately for ruptured and unruptured aneurysms. Event rates were pooled across studies using random effects meta-analysis.
23
Subgroup interactions (analysis of covariates) were performed using an interaction test as described by Altman. 24 Heterogeneity across studies was evaluated using the I-squared statistic. 25 We performed Begg and Mazumdar rank correlation to evaluate bias. All statistical analyses were performed using the meta-analysis software package Comprehensive Meta-analysis (www.meta-analysis.com).
Results
Study Selection and Characteristics
A total of 252 articles were retrieved through the electronic literature search. Among these, 65 articles were selected by abstract review and analyzed in detail. Twenty-one studies met our inclusion criteria and are described in Table 1 . Three studies exclusively included patients with unruptured aneurysms (281 cases), [19] [20] [21] whereas 18 studies included mainly patients with ruptured IAs (1080 of 1230 patients; 87.8%). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] A total of 1511 patients were included in this study, and 1080 (71.5%) patients presented with SAH.
Endovascular Technique and Immediate Angiographic Outcomes
Balloon-assisted coiling was used in 5% of procedures (95% CI, 3%-8%). Stent-assisted coiling was performed in 3% of procedures (95% CI, 2%-7%). Secondary clipping was required in 3% of procedures (95% CI, 2%-6%). The remaining 89% (95% CI, 84%-94%) of patients were treated with coiling alone. Immediate complete/near complete occlusion rates were 66% (95% CI, 52%-78%). These data are summarized in Table 2 .
Perioperative Complications, Morbidity, and Mortality
Intraoperative rupture rate was 3% (95% CI, 2%-4%). Patients with unruptured aneurysms had lower rates of intraoperative rupture (1%; 95% CI, 0%-3%) than those with ruptured aneurysms (4%; 95% CI, 2%-6%; P=0.04). Transient neurological deficits occurred in 5% of cases, with no significant difference between patients with ruptured and unruptured aneurysms (P=0.76). Perioperative stroke occurred in 4% (95% CI, 3%-6%), with similar rates between patients with ruptured (5%; 95% CI, 3%-7%) and unruptured aneurysms (4%; 95% CI, 1%-14%; P=0.68).
Perioperative mortality rate was 14% (95% CI, 9%-21%) and was significantly higher among patients with ruptured aneurysms (23%; 95% CI, 17-30%) compared with those with unruptured aneurysms (1%; 95% CI, 0-6%; P<0.01). Permanent perioperative morbidity rates were 8%, with similar rates between patients with ruptured aneurysms (9%; 95% CI, 6%-14%) compared with those with unruptured aneurysms (5%; 95% CI, 2%-13%; P=0.28). These data are summarized in Table 3 .
Long-term Clinical and Angiographic Outcomes
Twelve months after treatment, 78% (95% CI, 66%-87%) of patients had either GR or MD. The rate of GR/MD in patients treated for unruptured aneurysms at 12 months was 93% (95% CI, 88%-96%), whereas the rate of GR/MD for patients treated for ruptured aneurysms was 66% (95% CI, 59%-72%). Studies that looked at mortality rate at 6 to 12 months demonstrated an overall mortality rate of 26% (95% CI, 18%-35%) for patients with ruptured aneurysms and 10% (95% CI, 1%-71%) for patients with unruptured aneurysms.
Complete/near complete occlusion rates were 74% (95% CI, 66%-80%) at 6 to 12 months of follow-up and 86% (95% CI, 74%-93%) at >12 months follow-up. Occlusion rates for ruptured aneurysms at >12 months after treatment were 87% (95% CI, 76%-93%) and 87% (95% CI, 59%-97%) for unruptured aneurysms. These findings are summarized in Table 4 .
Assessment of Publication Bias
The Begg and Mazumdar rank correlation test suggested publication bias (P=0.01) for study outcomes with minimal or moderate heterogeneity (I-squared <50%). For analyses associated with heterogeneity, evaluation of publication bias was not possible because statistical testing for funnel asymmetry assumes a fixed effect model with no heterogeneity.
Discussion
This meta-analysis demonstrates that endovascular treatment of ruptured and unruptured aneurysms in the elderly is effective but associated with a perioperative complication rate of 14%. Perioperative mortality rate in patients with unruptured aneurysm was 1%, and permanent morbidity was 5%. Permanent periprocedural morbidity and mortality rates for elderly SAH patients treated with endovascular coiling were 9% and 23%, respectively. The high mortality in this latter group often is the result of SAH and its complications rather than the endovascular procedure, per se. Immediate and longterm complete occlusion rates were 66% and 86%, respectively.
Clinical Outcome
Permanent morbidity for elderly patients with ruptured aneurysms ranges from 1% to 21%, and mortality ranges from 2% to 24%. 1, 7, 8, 16 In a recent study using the Nationwide Inpatient Sample, in-hospital mortality was ≈20% for patients with SAH who were 65 to 79 years of age and underwent endovascular coiling, and only 30% of patients were discharged home. 26 In our meta-analysis, we found that the permanent perioperative morbidity for elderly patients treated with endovascular coiling was 9%, and perioperative mortality was 23%.
In the International Subarachnoid Aneurysm Trial (ISAT) subset analysis of patients ≥65 years of age who were treated with endovascular coiling, 60% of these patients were independent after 1 year, and the mortality rate was 18%. In addition, ISAT found that ≈56% of surgically clipped elderly patients were independent at 1 year. In our study, we found that at 6 to 12 months after treatment, 56% of patients with SAH had GR/MD, whereas at >12-month follow-up, 66% of patients had GR/MD. Thus, the rate of good clinical outcome for elderly patients in our meta-analysis is slightly higher than ISAT patients treated with clipping or coiling. The ISAT subgroup analysis also showed that the location of the ruptured aneurysm had a marked influence on functional outcome depending on the treatment modality. In this subset, patients with middle cerebral artery aneurysms showed a trend toward better outcomes when treated with open surgery rather than with endovascular coiling. The opposite was true for elderly patients with ruptured internal carotid and posterior communicating artery aneurysms. 16 Because of the limitations of the studies included in our analysis, we were unable to account for aneurysm location and clinical outcomes. 
Stroke
July 2013
The Barrow Ruptured Aneurysm Trial (BRAT) is another recently published trial comparing clipping and coiling in patients with ruptured aneurysms. 27 This study found that poor outcome at 1 year was seen in 20.4% of patients in the coiling group and 33.9% of patients in the clipping group. Although findings were not stratified by age, in a multivariate analysis, it was demonstrated that >50 years of age and the use of clipping were both associated with a significantly higher rate of poor outcome at 1 year. Among patients with ruptured aneurysm who received >1 year of follow-up in our study, 22% had severe disability, and mortality occurred in 10% of patients. This rate is higher than that seen in BRAT; however, mean patient age for patients treated with coiling in BRAT was 54 years, whereas all patients in this meta-analysis were ≥65 years of age.
The International Study on Unruptured Intracranial Aneurysms (ISUIA) demonstrated that nonage stratified combined morbidity and mortality was 9.3% for patients who underwent endovascular coiling. At 1 year, overall morbidity and mortality was 9.8% for patients treated with endovascular coiling. Among surgical patients, combined perioperative morbidity and mortality was 13.7%, and overall morbidity and mortality at 1 year was 12.6%. ISUIA demonstrated that for patients with craniotomy, age was a strong predictor of outcome along with aneurysm diameter and location in the posterior circulation. For the endovascular cohort, age was CI indicates confidence interval. *Discordances between percentages calculated from the raw numbers and those calculated from the meta-analysis are attributable to the fact that the meta-analysis algorithm assigns greater weights to outcomes of articles with higher sample sizes. not a predictor of poor outcome. 28 One large study of the Nationwide Inpatient Sample demonstrated in-hospital mortality rates of 0.8% for patients 65 to 79 years of age and 2.4% for patients ≥80 years of age who were treated with coiling for unruptured aneurysm. 29 In this study, perioperative morbidity and mortality for elderly patients undergoing clipping was 27% and 2%, respectively. In our meta-analysis, we found a perioperative morbidity rate of 5% and a perioperative mortality rate of 1%. At 1 year, only 5% of patients had severe disability, and mortality occurred in 2% of patients.
Despite the low rates of poor clinical outcomes seen in our meta-analysis, it is important to consider these morbidity and mortality rates in the context of large studies on the natural history of unruptured aneurysms, such as the recently published Unruptured Cerebral Aneurysms Study (UCAS) of Japan. 30 In UCAS, the annual rate of rupture of previously unruptured aneurysms was <1% per year, with rates as low as 0.36% per year for aneurysms 3 to 4 mm in size. In this study, age of >70 years was not found to be an independent predictor of aneurysm rupture. Thus, given the low rate of rupture, it is important for clinicians to be judicious in selecting appropriate candidates for endovascular treatment.
Angiographic Outcome
This study demonstrates a mean rate of immediate complete/ near complete occlusion of 66% and 86% at long-term follow-up. These findings are similar to those in larger series that demonstrate immediate occlusion rates of 25% to 90% and long-term occlusion rates of 60% to 80%. 1, 7, 8, 16 The rates of complete/near complete occlusion at the first procedure also seems comparable to that observed in the general population of the ISUIA study (72%) but considerably lower than that observed in the ISAT (92.5%).
Limitations
Our study has several methodological limitations. Seven of the 21 studies included in this analysis used ≥65 years as their age cutoff, and the remainder used ≥70 years. Thus, the possibility that many patients between 65 and 70 years of age are not captured in this meta-analysis could introduce some bias. Clinical and angiographic follow-up times were variable, ranging from 6 to 58 months. Thus, data on clinical outcomes and long-term angiographic outcomes are limited by the hetereogeneity in follow-up. Another limitation of our study is the fact that the available evidence is observational, nonrandomized, and noncomparative. Data in the published literature are collected retrospectively, and details are often lacking. For example, data on aneurysm geometry were not available in many studies. Assessment of geometric characteristics of IAs is an important factor in treatment decisions, such as whether or not to use adjunctive devices like balloons or stents. Furthermore, given the low rate at which adjunct devices like balloons and stents were used in this study, there may have been case selection of aneurysms with favorable anatomic characteristics. This has an effect on the generalizability of the results. Finally, in patients with aneurysmal SAH, it is difficult to differentiate procedural-related morbidity from morbidity secondary to complications of SAH.
Using the Grading of Recommendations, Assessment, Development and Evaluation framework, the quality of evidence (confidence in estimates) is limited because of imprecision, heterogeneity, and methodological limitations of the studies included. [31] [32] [33] Our results were also associated with the possibility of publication bias. Therefore, it is plausible that some studies with worse outcomes have been performed and not published, distorting the evidence base. Nevertheless, this meta-analysis provides useful data to share with patients and families when assessing the risks of endovascular treatment in this age group and represents a benchmark against which future studies in this patient subgroup can be compared. With analysis of >1500 patients, this is currently the largest study examining outcomes of endovascular coiling of IAs in the elderly population.
Conclusion
Our meta-analysis suggests that endovascular treatment of IAs in the elderly is associated with high long-term occlusion rates. Given the morbidity and mortality associated with endovascular treatment of IAs in the elderly, careful patient selection, especially in the case of patients with unruptured aneurysm, is recommended.
